Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System

Size: px
Start display at page:

Download "Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System"

Transcription

1 Cancer Research UK Clinical Trials/Research Unit Glasgow Quality System BEATSON WEST OF SCOTLAND CANCER CENTRE POLICY ON THE AWARENESS AND TRAINING OF STAFF MANAGING PATIENTS WITHIN THE CONTEXT OF A CLINICAL TRIAL To: All staff involved in managing patients on clinical trials within NHS Greater Glasgow and Clyde Health Board From: Clinical Trials Executive Committee Date: 08 Oct INTRODUCTION This policy document describes the levels of awareness or training in Good Clinical Practice (GCP) required for staff who manage patients on clinical trials conducted within NHS Greater Glasgow and Clyde Health Board (NHSGG&C) which have been approved by the Beatson West of Scotland Cancer Centre s Clinical Trials Executive Committee, based on their levels of involvement with trial patients. It also describes the level of training in the individual trial protocol that is required by these staff. 2. BACKGROUND All staff who manage patients in clinical trials must understand what awareness and/or training they require to carry out their role. There are two specific areas of awareness and training; the principles of GCP and the specific protocol(s) for the trial(s) on which they are working. The levels of awareness or training in each of these domains will depend upon the nature of the activities that they are delegated to perform. These levels are targeted at all individuals who may perform activities within clinical trials, e.g. radiographers, pharmacy staff, auxiliary staff, doctors, nurses. 3. LEVELS OF TRIAL INVOLVEMENT There are 3 levels of involvement for staff that manage trial patients within the BWoSCC: Level 1: Activity that is specified in the trial protocol, but which is conducted in exactly the same way as in routine care, e.g. recording of BP or ECG, and is conducted by an individual who would normally perform these activities during routine care. Level 2: Activity that is specified within the trial protocol and is unique to the trial, but which is within the normal remit of clinical responsibility for that member of staff. For example: o The administration of IV Investigational Medicinal Product (IMP) by a nurse trained in the administration of IV drugs. o Following an approved local dispensing procedure by pharmacy staff. In practice, there are few other examples. Level 3: Activity that is trial-specific and does not fall within the normal remit of clinical responsibility for the individual. Many activities performed by sub-investigators, research nurses and lead pharmacy contacts will fall into this category. Appendix II contains a list of examples of duties that would be performed at the above levels. 4. LEVELS OF AWARENESS/TRAINING Page 1 of 5 Version 2: 08 Oct 2015

2 For each activity level, there are corresponding degrees of training required in GCP and also trial-specific training: Level 1: 1. GCP training a brief GCP awareness document will be available to these staff members to consult in their area of activity, but no record will be kept as to whether or not this document has been received by individuals. 2. Trial-specific training no trial specific training is required, and these staff will not be listed on trial delegation logs or training logs. The responsibility for protocol compliance will lie with the member of the trial team who is instructing the individual to carry out this activity. The fact that the individual carrying out the activity does so as part of clinical job is considered sufficient evidence of training in the activity. The individual is not delegated to perform any activity within the trial that is not part of their everyday practice. Level 2: 1. GCP training abbreviated training will be provided to all relevant staff prior to undertaking trial activity. For Example: For nurses administering IV IMPs, this training will be part of the Chemotherapy Course, which is mandatory for all such staff. For other staff groups this will be organised by the appropriate line managers. This training will be documented and traceable, but will not necessarily be subject to planned or documented review unless there are significant changes in training requirements. 2. Trial-specific training this will depend on the staff group. For example: Nursing staff in this category will be made aware that the patient is on a clinical trial and will be informed as to whom to contact regarding that trial in the event of any concerns/aes. The mode of this communication will be dependent on the activity, e.g. for IMP administration this information will be on the chemotherapy prescription. Pharmacy staff in this category will undertake trial-specific training in relation to the locally approved dispensing procedures. This training will be carried out by a member of the lead pharmacy contacts team or another member of the pharmacy team, using a cascade system. This training will be documented on a training log that is stored in the pharmacy site file for the project. Level 2-only staff will not be required to sign a delegation log, but their signature next to the activity (e.g. on the chemotherapy prescription) will constitute such signature and will be filed in the source documentation but not the Investigator Site File (ISF). Level 3: 1. GCP training full GCP training must be undertaken by this group. This will be certificated, traceable and subject to renewal in accordance with an agreed renewal schedule (currently every 2 years). Please refer to the NHS Greater Glasgow and Clyde policy on GCP. 2. Trial-specific training The Principal Investigator (PI) is ultimately responsible for the training of this group in all delegated activities within the trial. Trial-specific training logs should be maintained in the ISF and all individuals undertaking these activities will be delegated to do so by the PI and this will be recorded in the delegation log in the ISF. 3. Any member of staff who prescribes IMPs must undergo full GCP training and be listed on delegation logs. There may be some exceptions to the activities which would typically be carried out under Level 3 training, whereby certain activities may be carried out by staff who have Level 2 training only, for example, non-medical prescribing. However, this practice will only be permitted on a case by case basis, following a risk assessment by the trial Sponsor and subsequent agreement between the R&D Governance Department and the trial Sponsor. 5. CTEC REVIEW and RISK ASSESSEMENT When a trial is reviewed by CTEC, the committee will identify the level of research resource to be provided for each trial. In some circumstances (e.g. clinical trials operating within the Clinical Research Unit), all trial activity will be conducted by individuals who are fully training in the protocol and GCP (e.g. Research nurses, doctors and lead pharmacy contacts). In such cases, it may be irrelevant what levels of activity are to be undertaken. When this is not the case, the CTEC Chair will conduct a risk assessment to identify any duties that fall within Level 2 (as documented in Section 3, above). Page 2 of 5 Version 2: 08 Oct 2015

3 6. RETENTION OF THE POLICY DOCUMENT This policy is accessed via the public area of the CRUK CTU website. Document control, distribution and retention are managed by the CRUK CTU Quality Assurance Manager, who is responsible for ensuring that the correct version is always available, the document is reviewed appropriately and timeously, and that superseded versions are archived appropriately. 7. REFERENCES NHS Greater Glasgow and Clyde Good Clinical Practice Policy 8. DOCUMENT HISTORY Version Approved Effective Reviewed Comments Version 1 11 Jan Jan Jul 2015 Additions to text in Sections 1 and 4. Addition of Section 6 Retention of the document. Version 2 Version 3 (Revision author: Michaela Rodger) Page 3 of 5 Version 2: 08 Oct 2015

4 Appendix I How do I know my patient is in a clinical study? The patient s case records will have a white sticker CLINICAL TRIAL PATIENT Please check inside notes for any instructions pertaining to the study CTU Contact for Study: CTC: Ext: Study No: Why do I need to know? For patient safety The Research Team for each study is responsible for the conduct of the study in this hospital. This includes reporting patient events which may be linked to their study participation to regulatory authorities. Please note All clinicians must report any Serious Adverse Events to the CTU immediately and fully document the event in case notes The Patient Information Sheet (PIS) and consent form will be filed in the case records along with the orange registration/randomisation sheet The Chemocare prescription identifies o the Beatson Study Number o which treatments are Investigational Medicinal Product (IMP) o the Research Team contact details What do I need to report? The Research Team need to know Any hospital admissions Any change to the patient treatment schedule Any abnormal observation parameters Any treatment compliance concerns Document in the case records and contact the Research Team Who should I ask? Every study has a Principal Investigator and a Clinical Trial Coordinator. Where possible there is also a Research Nurse assigned to the study. A general query? Contact the Clinical Trial Coordinator (CTC) A treatment related query? Contact the treatment prescribing medic or clinical trial pharmacist A concern about the study? The Principal Investigator, the local clinician responsible for the study Page 4 of 5 Version 2: 08 Oct 2015

5 Appendix II Examples of duties categorised as levels 1, 2 and 3 Level Duties Staff Group 1 Blood pressure Nursing 1 Pulse Nursing 1 Temperature Nursing 1 Respirations Nursing 1 Pulse Oximetry Nursing 1 Height Nursing 1 Weight Nursing 1 Urinalysis Nursing 1 Urine pregnancy test Nursing 1 ECG recording Nursing 1 Blood glucometer recording Nursing 1 Phlebotomy Nursing 1 Cannulation Nursing 1 Administration of IV drugs which are non IMP (NIMP) Nursing 1 Administration of IV chemotherapy which are NIMP Nursing 1 Administration of subcutaneous and intramuscular drugs which are NIMP Nursing 1 Administration or oral drugs which are NIMP Nursing 1 Administration of oral chemotherapy which are NIMP Nursing 2 Administration of trial drugs which are IMP Nursing 2 Receipt of IMP Pharmacy 2 Environmental Temperature Monitoring Pharmacy 2 Dispensing of NIMP Pharmacy 2 Dispensing of IMP for Phase II-IV trials Pharmacy 2 Accountability of IMP Pharmacy 2 Reconciliation of IMP Pharmacy 2 Destruction of IMP with sponsor approval Pharmacy 3 Any trial activity not covered by levels 1 and 2 Page 5 of 5 Version 2: 08 Oct 2015

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6 1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained

More information

STANDARD OPERATING PROCEDURE SOP 325

STANDARD OPERATING PROCEDURE SOP 325 STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author

More information

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally

More information

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research

More information

Setting up a Clinical Trial

Setting up a Clinical Trial York Foundation Trust R&D Unit SOP Pharm/S45 Setting up a Clinical Trial IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING USED All staff should regularly check

More information

Trial Management: Trial Master Files and Investigator Site Files

Trial Management: Trial Master Files and Investigator Site Files Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and

More information

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation

More information

STH Researcher. Recording of research information in patient case notes

STH Researcher. Recording of research information in patient case notes STANDARD OPERATING PROCEDURE STH Researcher Recording of research information in patient case notes SOP History None SOP Number A108 Created Research Department (AL) SUPERSEDED Final 1.3 Version 3.5 Date

More information

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored

More information

1. INTRODUCTION 2. SCOPE 3. PROCESS

1. INTRODUCTION 2. SCOPE 3. PROCESS 1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of

More information

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead: Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of

More information

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July

More information

Keele Clinical Trials Unit

Keele Clinical Trials Unit Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or

More information

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role

More information

Document Title: Study Data SOP (CRFs and Source Data)

Document Title: Study Data SOP (CRFs and Source Data) Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004 Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and

More information

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection

More information

UHS Clinical Trials Assistant Development Programme:

UHS Clinical Trials Assistant Development Programme: UHS Clinical Trials Assistant Development Programme: Developing the research workforce and introducing new healthcare roles to support research nurses. Marie Nelson Matron Research and Development & Emma

More information

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette

More information

Document Title: Investigator Site File. Document Number: 019

Document Title: Investigator Site File. Document Number: 019 Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

Site Closedown Checklist for UoL Sponsored CTIMP Studies

Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site

More information

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved

More information

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018 Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:

More information

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG INFORMATION AND GUIDANCE SHEET FOR THE COMPLETION OF THE SITE SIGNATURE AND

More information

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection Authorship Team: Jemma Hughes, Tina Morgan, for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August

More information

Investigator Site File Standard Operating Procedure (SOP)

Investigator Site File Standard Operating Procedure (SOP) Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse

More information

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227 SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance

More information

GCP INSPECTION CHECKLIST

GCP INSPECTION CHECKLIST (This list is not all inclusive; item may be added &/or deleted as per the Study/Site/Sponsor/Lab) I. General. Name and address of the clinical trial site Tel. No. & e- mail:. Date of Inspection. Inspection

More information

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified

More information

A Screen patients G Review/Accountability/Sign off Form 2:Dosing Log M IMP Supply/Management. SAE clinical review/causality Assessment and Sign off

A Screen patients G Review/Accountability/Sign off Form 2:Dosing Log M IMP Supply/Management. SAE clinical review/causality Assessment and Sign off Site Delegation Log Study Name: Hospital: ELFIN EudraCT No: 2012-004260-22 REC Reference: 13/EM/0118 Title: Investigator: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December

More information

QUALITY ASSURANCE PROGRAM

QUALITY ASSURANCE PROGRAM QUALITY ASSURANCE PROGRAM Elaine Armstrong, MS Quality Assurance Manager PURPOSE Verify accuracy of submitted data Verify compliance with protocol and regulatory requirements Provide educational support

More information

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP) Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

More information

Checklist prior to recruiting first patient

Checklist prior to recruiting first patient Pre-Site selection Site Initiation Visit (SIV) What kind of questions should you ask How you should prepare for this visit Delegation logs Training logs ECRF/CRF Checklist prior to recruiting first patient

More information

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager Standard Operating Procedures (SOP) for: Pharmacovigilance processing for the JRMO SOP Number: 26c Version Number: V1 Effective Date: 5/8/16 Review Date: 5/8/17 Author: Reviewer: Reviewer: Authorisation:

More information

JOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.

JOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials. JOB DESCRIPTION JOB TITLE: Pharmacy Technician Haematology Clinical Trials PAY BAND: Agenda for change - Band 5 TERMS AND CONDITIONS DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PROFESSIONALLY RESPONSIBLE

More information

Standard Operating Procedure

Standard Operating Procedure Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced

More information

Storage and Archiving of Research Documents SOP 6

Storage and Archiving of Research Documents SOP 6 Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager

More information

STANDARD OPERATING PROCEDURE SOP 205

STANDARD OPERATING PROCEDURE SOP 205 STANDARD OPERATING PROCEDURE SOP 205 Adverse Events: Identifying, Recording and Reporting for CTIMPs Sponsored by the Norfolk and Norwich University Hospital NHS Foundation Trust Version 2.3 Version date

More information

Joint R&D Support Office SOP S-2011 UHL

Joint R&D Support Office SOP S-2011 UHL UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES Joint R&D Support Office SOP S-2011 UHL Site Initiation for

More information

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff Department Title of SOP Research & Development Case Report Form SOP SOP reference no: R&D GCP SOP 03 Authors: Current version number and date: J H Pacynko and J Illingworth Version 2, 01.02.18 Next review

More information

SYSTEMS 2 (L160) A Randomised Phase II trial of standard versus dose escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma

SYSTEMS 2 (L160) A Randomised Phase II trial of standard versus dose escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma SYSTEMS 2 (L160) A Randomised Phase II trial of standard versus dose escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma ISRCTN No: ISRCTN12698107 Protocol No: SYSTEMS 22015

More information

Standard Operating Procedure Research Governance

Standard Operating Procedure Research Governance Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision

More information

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Delegation of Responsibilities SOP Reference QUB-ADRE-005 Date prepared 23 June 2008 Number: Version

More information

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)

More information

Document Title: Document Number:

Document Title: Document Number: including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate

More information

Safety Reporting in Clinical Research Policy Final Version 4.0

Safety Reporting in Clinical Research Policy Final Version 4.0 Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent

More information

Clinical Study Risk Assessment

Clinical Study Risk Assessment Clinical Study Risk Assessment Clinical S.O.P. No.: 19 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited number by 1.0 New SOP Shona

More information

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator I2S2 TRAINING Good Clinical Practice tips Deirdre Thom Neonatal Nurse Coordinator Content Principal investigator (slides 3-5) Delegation and delegation log (slides 6-7) Informed consent (slides 8-15) Data

More information

Standard Operating Procedure (SOP)

Standard Operating Procedure (SOP) Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP

More information

STANDARD OPERATING PROCEDURE SOP 345. Identifying Trial Patients on Hospital Admission

STANDARD OPERATING PROCEDURE SOP 345. Identifying Trial Patients on Hospital Admission STANDARD OPERATING PROCEDURE SOP 345 Identifying Trial Patients on Hospital Admission Version 1.3 Version date 22/02/2018 Effective date 24/02/2018 Number of pages 6 Review date January 2020 Author Role

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August

More information

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

This Agreement dated DD/MM/YYYY (the Effective Date ) is between Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7

More information

Prescribing Lactoferrin in the ELFIN Clinical trial

Prescribing Lactoferrin in the ELFIN Clinical trial Prescribing Lactoferrin in the ELFIN Clinical trial PAULA JENKINS RESEARCH NURSE NPEU Why Lactoferrin is deemed an Investigational Medicinal Product any substance or combination of substances presented

More information

COMPETENCY FRAMEWORK

COMPETENCY FRAMEWORK COMPETENCY FRAMEWORK Theresa Ledger Lead Nurse Research and Development Clinical Research Facility Sheffield C:\Documents and Settings\Robertus\My Documents\Mariann\CRF\CRF Portfolio and Competency Template_DRAFT

More information

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK

More information

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)

More information

CLINICAL TRIALS ASSISTANT - BEATSON CLINICAL TRIALS UNIT Boc Trials Unit Beatson West of Scotland Cancer Centre

CLINICAL TRIALS ASSISTANT - BEATSON CLINICAL TRIALS UNIT Boc Trials Unit Beatson West of Scotland Cancer Centre CLINICAL TRIALS ASSISTANT - BEATSON CLINICAL TRIALS UNIT Boc Trials Unit Beatson West of Scotland Cancer Centre Job Reference: 0000051660G Closing Date: 25 May 2018 Dear applicant, Thank you for your interest

More information

Research Staff Training

Research Staff Training REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa

More information

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:

More information

Keele Clinical Trials Unit

Keele Clinical Trials Unit Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017

More information

SFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check

SFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check Overview This standard describes the skills, knowledge and understanding required to demonstrate competence

More information

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Document Title: GCP Training for Research Staff. Document Number: SOP 005 Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:

More information

Adverse Event Reporting

Adverse Event Reporting Adverse Event Reporting Clinical S.O.P. No.: 15 Compiled by: Approved by: Review date: November 2016 DOCUMENT HISTORY Version Detail of purpose / change Author / edited Date edited number by 1.0 New SOP

More information

Policy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition)

Policy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition) Policy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition) Document Summary This Policy defines the clinical procedures for all Clinical staff (including temporary staff, contracted

More information

DESTRUCTION AND RETENTION OF CLINICAL HEALTH RECORDS POLICY

DESTRUCTION AND RETENTION OF CLINICAL HEALTH RECORDS POLICY Directorate of Operations Central Operations Group Corporate Library Services DESTRUCTION AND RETENTION OF CLINICAL HEALTH RECORDS POLICY Reference: OPP023 Version: 1.7 This version issued: 02/05/12 Result

More information

R. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager

R. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager Standard Operating Procedures (SOP) for: BH/QMUL Sponsorship of CTIMPs, ATMPs and Clinical Trials of non- CE marked Medicinal Devices Process for Researchers SOP Number: 11a Version Number: V1.0 Effective

More information

Prescribing and Administration of Medication Procedure

Prescribing and Administration of Medication Procedure Prescribing and Administration of Medication Procedure Version: 3.3 Bodies consulted: - Approved by: PASC Date Approved: 1.4.16 Lead Manager Lead Director: Head of Child and Adolescent psychiatry Medical

More information

Recommendations for the Retention of Pharmacy Records - prepared by the East of England NHS Senior Pharmacy Managers

Recommendations for the Retention of Pharmacy Records - prepared by the East of England NHS Senior Pharmacy Managers Recommendations for the Retention of Pharmacy s - prepared by the East of England NHS Senior Pharmacy Managers 2012-13 RECORDS THAT PERTAIN TO ALL PHARMACY SETTINGS Clinical governance Competency/training

More information

Auditing of Clinical Trials

Auditing of Clinical Trials Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May

More information

Assessment criteria The learner can:

Assessment criteria The learner can: HSC 3052: Undertake measurements Unit reference R/601/8662 Level 3 Credit value 3 GLH 23 Unit aim This unit is aimed at health & social care staff involved in the taking and ing of measurements as part

More information

CLINICAL TRIAL COORDINATOR Clinical Trials Unit Beatson West of Scotland Cancer Centre

CLINICAL TRIAL COORDINATOR Clinical Trials Unit Beatson West of Scotland Cancer Centre CLINICAL TRIAL COORDINATOR Clinical Trials Unit Beatson West of Scotland Cancer Centre Job Reference: 0000046503G Closing Date: 7 th April 2017 Dear applicant, Thank you for your interest in this post

More information

Effective Date: 11/09 Policy Chronicle:

Effective Date: 11/09 Policy Chronicle: Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:

More information

MINNESOTA. Downloaded January 2011

MINNESOTA. Downloaded January 2011 MINNESOTA Downloaded January 2011 4658.1300 MEDICATIONS AND PHARMACY SERVICES; DEFINITIONS. Subpart 1. Controlled substances. "Controlled substances" has the meaning given in Minnesota Statutes, section

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:

More information

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements 6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services

More information

Management of Reported Medication Errors Policy

Management of Reported Medication Errors Policy Management of Reported Medication Errors Policy Approved By: Policy & Guideline Committee Date of Original 6 October 2008 Approval: Trust Reference: B45/2008 Version: 4 Supersedes: 3 February 2015 Trust

More information

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:

More information

Guidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities. July 2011

Guidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities. July 2011 Guidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities July 2011 Introduction: This guidance sets out strengthened governance arrangements required

More information

Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by

Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by Contract Research Organisations (CRO mcia, 2011 version)

More information

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Patricia Fischer, RN, CCRP Investigator Responsibilities FDA Draft Guidance May 2007 Clarifies FDA s expectations,

More information

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic

More information

Central Alerting System (CAS) Policy

Central Alerting System (CAS) Policy Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)

More information

Monitoring Clinical Trials

Monitoring Clinical Trials This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

STANDARD OPERATING PROCEDURE SOP 220. Investigation of allegations of Research Fraud and Misconduct. NNUH UEA Joint Research Office

STANDARD OPERATING PROCEDURE SOP 220. Investigation of allegations of Research Fraud and Misconduct. NNUH UEA Joint Research Office STANDARD OPERATING PROCEDURE SOP 220 Investigation of allegations of Research Fraud and Misconduct Version 1.4 Version date 27.02.2018 Effective date 2.03.2018 Number of pages 8 Review date February 2020

More information

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES DOCUMENT NO.: CR012 v2.0 AUTHOR: Raymond French ISSUE DATE: 18 September 2017 EFFECTIVE DATE: 02 October

More information

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION SOP: NN SS 401 Version No.: 2.0 Effective Date: 21Oct2016 SITE SELECTION AND QUALIFICATION Supercedes Document:

More information

Document Title: Research Database Application (ReDA) Document Number: 043

Document Title: Research Database Application (ReDA) Document Number: 043 Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of

More information

Standard Operating Procedures

Standard Operating Procedures Standard Operating Procedures 5.7 Site Initiation Version V1.0 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 30/09/2017 Review date 30/09/2019 DO NOT USE THIS SOP IN PRINTED FORM WITHOUT

More information

Clinical Trial Readiness Checklist October 2014

Clinical Trial Readiness Checklist October 2014 The clinical trial readiness checklist is a tool which can help new and experienced researchers prepare for upcoming clinical studies. It is designed to be a quick reference to ensure that you have the

More information

Study Monitoring Plan Template

Study Monitoring Plan Template Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &

More information

Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;

Once the feasibility assessment has been conducted the study team will be notified via  (Appendix 3) of the outcome and whether the study is; 1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment

More information

ORAL ANTI-CANCER THERAPY POLICY

ORAL ANTI-CANCER THERAPY POLICY ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive

More information

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)

More information